Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Allertec Allergy Relief (Pharmacy only)
Active Ingredient: Cetirizine hydrochloride 10mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: AdiraMedica Pty Limited.
Manufacturer: Softgel Healthcare Pvt. Limited, Kancheepuram, India
   
Product: Allertec Hayfever Relief (General sale)
Active Ingredient: Cetirizine hydrochloride 10mg
Dosage Form: Soft gelatin capsule
New Zealand Sponsor: AdiraMedica Pty Limited.
Manufacturer: Softgel Healthcare Pvt. Limited, Kancheepuram, India
   
Product:   ENHERTU  
 Active Ingredient: Trastuzumab deruxtecan 100mg
Dosage Form: Powder for concentrate for infusion
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: Baxter Oncology GmbH, Halle-Kunsebeck Westfalen, Germany
   
Product: Mayzent
Active Ingredient: Siponimod fumarate 1.112mg equivalent to siponimod 1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
   
Product: Uramet
Active Ingredient: Methenamine hippurate 1g
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Aspen Pharma Pty Limited, Melbourne, Australia


Dated this 4th day of December 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).